BSE filing, NSE: NEPHROPLUS. Summary written from the filing by ALFA Finder's alert engine.
Nephrocare Health Services Ltd: key numbers
- Share price
- ₹624.60
- Market cap
- ₹6,267 Cr
- Revenue (annual)
- ₹998.8 Cr
- Net profit (annual)
- ₹76.84 Cr
- P/E (TTM)
- 73.6×Sector 53.7×
- Promoter holding
- 58.31%-5.54% QoQ
- FII holding
- 11.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephrocare Health Services Ltd
All →Nephrocare Health Services Investor Presentation: Key Takeaways
H1FY27 revenue ₹585.2 Cr (+23.6% YoY), Adj EBITDA ₹134.4 Cr (+15.3%), Adj PAT ₹76.1 Cr (+34.7%). Expansion via acquisitions in Philippines, Kazakhstan and Saudi Arabia.
Nephrocare Health Services Results Update
Nephrocare Health Services released its Q2 and H1 FY27 results press release. Revenue and adjusted profit grew year-on-year, alongside network expansion into Kazakhstan.
Nephrocare Health Services Q2 FY27 Results: Turns Profitable, Net Profit ₹33.5 Cr
Nephrocare Health Services Ltd reported revenue from operations of ₹303.4 Cr (+23.5% YoY) and net profit of ₹33.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹33.5 Cr
Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Nephrocare Health Services Acquisition
Nephrocare's Philippines subsidiary agreed to acquire dialysis center assets from JCM Summit Health under an Asset Transfer Agreement. Consideration is undisclosed but the deal exceeds materiality thresholds.
Nephrocare Health Services Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Other other announcement announcements
All →BAG Convergence Other Announcement
B.A.G. Convergence submitted its IPO monitoring agency report for the half year ended September 30, 2026, which records no deviation from the objects. The IPO raised Rs 48.72 Crore.
Halder Venture Other Announcement
Halder Venture reports no deviation in use of proceeds from its preferential warrant issue for the quarter ended September 30, 2026. The filing is a routine Regulation 32 statement confirming funds are used as stated.
Shanti Gold International Other Announcement
Shanti Gold International filed its IPO monitoring agency report for the quarter ended September 2026, citing no deviation from objects. The report flags that utilisation of proceeds is delayed.
Jyoti Structures Other Announcement
Jyoti Structures filed its quarterly monitoring agency report on rights issue proceeds. No proceeds were used in the quarter, and the utilisation deadline was extended to March 2027.
Lloyds Metals & Energy Other Announcement
Lloyds Metals filed ACER's monitoring agency report on preferential warrant proceeds for the quarter ended September 30, 2026. It reports no deviation from stated objects and no major deviation.
Tarai Foods Other Announcement
Tarai Foods filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing reports routine ownership data with no transaction or material event.